1. Home
  2. ZLAB vs STRL Comparison

ZLAB vs STRL Comparison

Compare ZLAB & STRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • STRL
  • Stock Information
  • Founded
  • ZLAB 2013
  • STRL 1955
  • Country
  • ZLAB China
  • STRL United States
  • Employees
  • ZLAB N/A
  • STRL N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • STRL Military/Government/Technical
  • Sector
  • ZLAB Health Care
  • STRL Industrials
  • Exchange
  • ZLAB Nasdaq
  • STRL Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • STRL 3.8B
  • IPO Year
  • ZLAB 2017
  • STRL N/A
  • Fundamental
  • Price
  • ZLAB $29.24
  • STRL $177.74
  • Analyst Decision
  • ZLAB Buy
  • STRL Strong Buy
  • Analyst Count
  • ZLAB 4
  • STRL 2
  • Target Price
  • ZLAB $47.37
  • STRL $185.00
  • AVG Volume (30 Days)
  • ZLAB 1.2M
  • STRL 1.1M
  • Earning Date
  • ZLAB 05-08-2025
  • STRL 05-05-2025
  • Dividend Yield
  • ZLAB N/A
  • STRL N/A
  • EPS Growth
  • ZLAB N/A
  • STRL 78.58
  • EPS
  • ZLAB N/A
  • STRL 8.56
  • Revenue
  • ZLAB $418,326,000.00
  • STRL $2,106,345,000.00
  • Revenue This Year
  • ZLAB $44.43
  • STRL N/A
  • Revenue Next Year
  • ZLAB $48.68
  • STRL $7.82
  • P/E Ratio
  • ZLAB N/A
  • STRL $20.77
  • Revenue Growth
  • ZLAB 43.72
  • STRL 4.84
  • 52 Week Low
  • ZLAB $15.65
  • STRL $93.50
  • 52 Week High
  • ZLAB $39.77
  • STRL $206.07
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 42.71
  • STRL 75.61
  • Support Level
  • ZLAB $27.61
  • STRL $143.20
  • Resistance Level
  • ZLAB $32.02
  • STRL $183.87
  • Average True Range (ATR)
  • ZLAB 1.23
  • STRL 7.47
  • MACD
  • ZLAB -0.18
  • STRL 3.02
  • Stochastic Oscillator
  • ZLAB 23.41
  • STRL 88.13

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions. .

Share on Social Networks: